In vitro and in vivo biological activity of PEDF against a range of tumors

被引:70
作者
Broadhead, Matthew L. [1 ]
Dass, Crispin R. [1 ]
Choong, Peter F. M. [1 ]
机构
[1] Univ Melbourne, St Vincents Hosp, Dept Orthopaed & Surg, Fitzroy, Vic 3065, Australia
关键词
angiogenesis; cancer; PEDF; therapy; tumor; EPITHELIUM-DERIVED FACTOR; ORTHOTOPIC OSTEOSARCOMA GROWTH; PIGMENT-EPITHELIUM; NEUROTROPHIC ACTIVITY; NONINHIBITORY SERPIN; MALIGNANT-MELANOMA; FACTOR EXPRESSION; PROSTATE-CANCER; GENE-EXPRESSION; DOWN-REGULATION;
D O I
10.1517/14728220903307475
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Background: Pigment epithelium-derived factor (PEDF) is an emerging anticancer agent that targets both tumor tissue and its supporting vasculature. These direct and indirect effects of PEDF have been examined in vitro and in vivo for a range of malignancies. Objective: This review seeks to present PEDF as a potential anti-cancer agent with applications across multiple malignancies. We refer closely to experimental methodology whilst still highlighting the clinical significance of PEDF in cancer, drawing on biological findings in vitro and in vivo. Methods: A Pubmed database search was performed limiting the scope of this discussion paper mainly to PEDF's biological role in cancer, specifically lung, breast, prostatic, ovarian and pancreatic carcinomas, melanoma, glioma and osteosarcoma. Conclusions: The biological roles of PEDF are diverse and multidimensional. As an anti-cancer agent, PEDF has great potential as a focused anti-neoplastic therapy against a variety of tumor types.
引用
收藏
页码:1429 / 1438
页数:10
相关论文
共 51 条
[1]
Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo [J].
Abe, R ;
Shimizu, T ;
Yamagishi, S ;
Shibaki, A ;
Amano, S ;
Inagaki, Y ;
Watanabe, H ;
Sugawara, H ;
Nakamura, H ;
Takeuchi, M ;
Imaizumi, T ;
Shimizu, H .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) :1225-1232
[2]
Abe R, 2007, MINI-REV MED CHEM, V7, P649
[3]
[Anonymous], 2010, Robbins and Cotran pathologic basis of disease, professional edition e-book
[4]
Focus on molecules: Pigment epithelium-derived factor (PEDF) [J].
Becerra, SP .
EXPERIMENTAL EYE RESEARCH, 2006, 82 (05) :739-740
[5]
Becerra SP, 1997, ADV EXP MED BIOL, V425, P223
[6]
PIGMENT EPITHELIUM-DERIVED FACTOR BEHAVES LIKE A NONINHIBITORY SERPIN - NEUROTROPHIC ACTIVITY DOES NOT REQUIRE THE SERPIN REACTIVE LOOP [J].
BECERRA, SP ;
SAGASTI, A ;
SPINELLA, P ;
NOTARIO, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) :25992-25999
[7]
Decreased pigment epithelium-derived factor expression in human breast cancer progression [J].
Cai, Jun ;
Parr, Christian ;
Watkins, Gareth ;
Jiang, Wen G. ;
Boulton, Mike .
CLINICAL CANCER RESEARCH, 2006, 12 (11) :3510-3517
[8]
Cao W, 1999, J NEUROSCI RES, V57, P789, DOI 10.1002/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.3.CO
[9]
2-D
[10]
Chen Jin-Feng, 2009, Zhonghua Yi Xue Za Zhi, V89, P485